Chapel Hill, NC, United States of America

Masuo Goto

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: China Medical University Hospital, The University of North Carolina at Chapel Hill. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masuo Goto. Retrieved from https://idiyas.com/inventor/masuo-goto-aof0tnep

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 21.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masuo Goto: Innovator in Antitumor Agents

Introduction

Masuo Goto is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of antitumor agents. His work focuses on novel compounds that have the potential to treat various types of cancer.

Latest Patents

Masuo Goto holds 1 patent related to his research. The patent involves novel 20-sulfonylamidine derivatives of camptothecin, a compound known for its antitumor properties. This invention outlines a method for synthesizing these derivatives and their application as an antitumor agent, specifically for treating nasopharyngeal, lung, breast, or prostate cancer.

Career Highlights

Throughout his career, Masuo Goto has worked with esteemed institutions such as China Medical University Hospital and the University of North Carolina at Chapel Hill. His research has contributed to advancements in cancer treatment and has garnered attention in the scientific community.

Collaborations

Masuo Goto has collaborated with notable colleagues, including Kuo-Hsiung Lee and Keduo Qian. These partnerships have enhanced his research efforts and expanded the impact of his work in the field of oncology.

Conclusion

Masuo Goto's innovative contributions to the development of antitumor agents highlight his dedication to advancing cancer treatment. His work continues to inspire future research in medicinal chemistry and oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…